Sanofi teams up with Evotec, Apeiron to develop immuno-oncology pills

PARIS, Aug 10 (Reuters) - Sanofi is teaming up with Germany's Evotec and Austrian biotech firm Apeiron Biologics to develop a new type of immune system-boosting cancer medicine that could be given as tablets to fight both solid tumours and blood cancers.